Détail de l'auteur
Auteur J. VICENTE |
Documents disponibles écrits par cet auteur (40)
Article : Périodique
L. KRAUS ; N. N. SEITZ ; D. PIONTEK ; S. MOLINARO ; V. SICILIANO ; U. GUTTORMSSON ; S. ARPA ; K. MONSHOUWER ; H. LEIFMAN ; J. VICENTE ; P. GRIFFITHS ; L. CLANCY ; F. FEIJAO ; S. FLORESCU ; P. LAMBRECHT ; A. NOCIAR ; K. RAITASALO ; S. SPILKA ; K. VYSHINSKIY ; B. HIBELL |AIMS: To estimate temporal trends in adolescents' current cigarette, alcohol and cannabis use in Europe by gender and region, test for regional differences and evaluate regional convergence. DESIGN AND SETTING: Five waves of the European School[...]Rapport
H. SUMNALL ; M. A. BELLIS ; A. LODWICK ; T. BUCKE ; J. VICENTE | Lisbon : OEDT / EMCDDA | Methodological studies | 2005This is the final report of the EMCDDA project the 'European databank on population surveys on drugs,' which consisted of a voluntary compilation of original databases of existing surveys and their results. The aim of the project was to re-appro[...]Rapport
OEDT = EMCDDA ; L. MONTANARI ; M. PASINETTI ; D. THANKI ; J. VICENTE | Lisbon : OEDT / EMCDDA | EMCDDA Papers, ISSN 2315-1463 | 2013Identifying the co-occurrence of drug use and mental health disorders in the same individuals is essential for effective treatment of their drug use problems. Reviewing the available information on psychiatric co-morbidity among drug users in Eu[...]Rapport
M. VAN LAAR ; G. CRUTS ; R. HARTNOLL ; J. VICENTE | Lisbon : OEDT / EMCDDA | Scientific Reports | 2001Data on drug-related deaths count as one of the five epidemiological key-indicators of the EMCDDA to be implemented in the Member States of the European Union. However, figures on drug-related deaths are not directly comparable between countries[...]Article : Périodique
G. MENA ; I. GIRAUDON ; E. ALVAREZ ; J. M. CORKERY ; J. MATIAS ; K. GRASAASEN ; N. LLORENS ; P. GRIFFITHS ; J. VICENTE |Background: Cocaine-related health consequences are difficult to observe. Data on drug users in health-emergency settings may be a useful source of information on consequences that are not visible via other information sources. Methods: Thirty[...]Rapport
OEDT = EMCDDA ; M. TORRENS ; J. I. MESTRE-PINTO ; A. DOMINGO-SALVANY ; L. MONTANARI ; J. VICENTE | Lisbon : OEDT / EMCDDA | Insights, ISSN 1606-1683 | 2015This publication looks at the co-occurrence of drug use problems and mental health disorders, taking in the theoretical background of psychiatric comorbidity, the tools for clinical diagnosis and the prevalence and clinical relevance of the prob[...]Périodique
L. MONTANARI ; FELGUEIRAS G. ; P. GRIFFITHS ; J. VICENTE | 2004ENGLISH : Over the last several years, many European countries have seen an increase in treatment requests from the public for cannabis use. From 1996 to 2002 demand for treatment has increased by 20%. Although several outside factors have con[...]Rapport
OEDT = EMCDDA ; I. GIRAUDON ; F. MATHIS ; D. HEDRICH ; J. VICENTE ; A. NOOR | Lisbon : OEDT / EMCDDA | Technical reports | 2021This report provides an update on drug-related deaths in Europe based primarily on presentations and discussions held at the 2019 meeting of the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) expert network on drug-related deat[...]Document texte divers
EMCDDA Conference on 20 years of monitoring and communicating evidence on drugs (21-22 September 2015; Lisbon) ; I. GIRAUDON ; J. MATIAS ; L. MONTANARI ; D. HEDRICH ; R. SIMON ; J. VICENTE | Lisbon : OEDT / EMCDDA | 2015Drug use, in particular high-risk drug use, is one of the major causes of avoidable mortality among young people in Europe, both directly through overdose and indirectly through drug-related diseases, accidents, violence and suicide. The Drug-r[...]Document texte divers
EMCDDA Conference on 20 years of monitoring and communicating evidence on drugs (21-22 September 2015; Lisbon) ; I. GIRAUDON ; L. WIESSING ; E. KALAMARA ; D. HEDRICH ; R. SIMON ; K. PALCZAK ; J. VICENTE | Lisbon : OEDT / EMCDDA | 2015Drug-related infectious diseases (DRID) are among the most serious health consequences of drug use. The DRID indicator collects data on the extent of drug-related infections among people who inject drugs. This group is a key population affected [...]Article : Périodique
A. M. BARGAGLI ; M. HICKMAN ; M. DAVOLI ; C. A. PERUCCI ; P. SCHIFANO ; M. BUSTER ; T. BRUGAL ; J. VICENTE |ENGLISH : Objective: To estimate the mortality rates from drug-related deaths and other causes among problem drug users and population attributable risk of death due to opiate use in eight study sites in Europe. Methods: Opiate users were recr[...]Rapport
OEDT = EMCDDA ; L. ROYUELA ; L. MONTANARI ; M. ROSA ; J. VICENTE | Lisbon : OEDT / EMCDDA | Technical reports | 2014The report presents a review of tools for monitoring illicit drug use in prison population in Europe. The objective of the report is to describe the existing tools used at national level, to assess their comparability and to build a common Europ[...]Rapport
The protocol establishes harmonised criteria to extract process and report cases, based on the information available, at the end point of the chain of certification/ascertainment procedures, at different mortality registries: General Mortality R[...]Périodique
OEDT = EMCDDA ; I. GIRAUDON ; G. MENA ; J. MATIAS ; J. VICENTE | Lisbon : OEDT / EMCDDA | Technical reports | 2014This study reveals the substantial levels of morbidity related to cocaine use, translated into the large number of cocaine cases seen in various emergency settings in European countries. This health burden is often not captured by other traditio[...]Rapport
OEDT = EMCDDA ; A. SARASA-RENEDO ; G. BARRIO ; L. MONTANARI ; B. GUARITA ; L. DE LA FUENTE ; M. J. BRAVO ; J. VICENTE | Lisbon : OEDT / EMCDDA | Technical reports | 2015FRANÇAIS : Ce rapport décrit les tendances en matière d'injection de drogues dans les États membres de l'UE, la Norvège et la Turquie entre 2000 et 2011, à travers une analyse des données relatives aux personnes recevant un traitement médicamen[...]Rapport
OEDT = EMCDDA ; L. MONTANARI ; L. ROYUELA ; M. ROSA ; J. VICENTE | Lisbon : OEDT / EMCDDA | Technical reports | 2014This is a first common questionnaire on drug use among prisoners at European level. The questionnaire is the results of two years of work in the field of drugs and prison, which has included the agreement on a methodological framework or monitor[...]Rapport
T. RHODES ; M. BARNARD ; J. FOUNTAIN ; F. HARIGA ; N. R. AVILES ; J. VICENTE ; U. WEBER | Lisbon : OEDT / EMCDDA | Insights, ISSN 1606-1683 | 2001ENGLISH : This study explores the role of qualitative research in understanding the lived experience, social meanings and contexts of injecting drug use and risk behaviour in the time of AIDS, based on the findings of an EMCDDA working group i[...]Rapport
M. DE WINTER ; P. COHEN ; M. LANGEMIJER ; J. VICENTE ; R. HARTNOLL | 2000This report describes the affect of using different survey modes on the measurement of substance use prevalence figures. Three different modes were included in the design of this study: a telephone, a postal, and a face to face survey-mode. The [...]Rapport
OEDT = EMCDDA ; I. GIRAUDON ; M. BUSTER ; A. ESPELT ; J. MATIAS ; J. VICENTE | Lisbon : OEDT / EMCDDA | EMCDDA Papers, ISSN 2315-1463 | 2015This paper examines the overall number of lives lost due to drug use. All-cause mortality among problem drug users is investigated by means of cohort studies, which link data from death registries to drug treatment records. Building on earlier w[...]Périodique
A. M. BARGAGLI ; SPERATI A. ; M. DAVOLI ; C. PERUCCI ; J. VICENTE ; R. HARTNOLL ; J. BARRY ; T. BRUGAL ; M. BUSTER ; F. FERRAZ DE OLIVEIRA ; HAASTRUP L. ; A. HEINEMANN ; KOUKLINOS A. ; D. RISSER ; SVENSSON D. ; VUORI E. | 2002ENGLISH : The European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) is currently coordinating a project which aims to enrol and follow up prospective cohorts of problem drug users (PDUs) in several countries, so as to compare overal[...]Article : Périodique
H. LOPEZ-PELAYO ; J. VICENTE ; A. GALLEGOS ; A. McAULEY ; Y. BUYUK ; M. WHITE ; I. GIRAUDON |Background-Aims: New psychoactive substances (NPS) are new narcotic or psychotropic drugs that are not controlled by the drug conventions of the United Nations. In the last 10 years, numerous NPS have been identified in Europe but there is no co[...]Rapport
C. A. PERUCCI ; A. M. BARGAGLI ; M. DAVOLI ; SPERATI A. ; R. HARTNOLL ; J. VICENTE | Lisbon : OEDT / EMCDDA | Scientific Reports | 2005ENGLISH : Since 1996, the Department of Epidemiology ASL RM E, Rome, Italy has been coordinating a project promoted by the EMCDDA, aimed to produce and compare mortality rates estimates across European countries by the implementation of coho[...]Périodique
J. SANCHEZ ; B. RODRIGUEZ ; L. DE LA FUENTE ; G. BARRIO ; J. VICENTE ; J. ROCA ; L. ROYUELA | 1995FRANÇAIS : Les caractéristiques démographiques et épidémiologiques de personnes décédées entre 1983 et 1991 ont été étudiées dans les villes de Madrid, Barcelone, Valence, Séville, Saragosse et Bilbao. Dans 2596 cas, l'attribution de la causali[...]Rapport
This document is a summary of the concepts and definitions in the revised area. Detailed background information about the process of revision can be found in two related documents. The changes are, for the most part, related to the theoretical c[...]Rapport
OEDT = EMCDDA ; D. THANKI ; J. MATIAS ; P. GRIFFITHS ; A. NOOR ; D. OLSZEWSKI ; R. SIMON ; J. VICENTE | Lisbon : OEDT / EMCDDA | Thematic Papers, ISSN 1725-5767 | 2012This report brings together, for the first time in Europe, an integrated overview of the prevalence of intensive cannabis use, defined as daily or almost daily cannabis use (use on 20 or more days in the month preceding survey). Self-reported da[...]Document texte divers
EMCDDA Conference on 20 years of monitoring and communicating evidence on drugs (21-22 September 2015; Lisbon) ; D. THANKI ; E. KALAMARA ; A. NOOR ; L. MONTANARI ; J. VICENTE | Lisbon : OEDT / EMCDDA | 2015Some drug users go on to develop more severe forms of use, defined by the EMCDDA as 'high-risk drug use': 'recurrent drug use that is causing actual harms (negative consequences) to the person (including dependence, but also other health, psycho[...]Article : Périodique
L. MONTANARI ; M. PASINETTI ; B. GUARITA ; L. ROYUELA ; K. MULLIGAN ; J. VICENTE ; D. KLEMPOVA ; A. PIRONA ; A. GYARMATHY |The aim of this article is to explore the prevalence of primary illicit stimulant use among people who enter drug treatment in Europe. Drawing on information provided by European Union treatment centres in 2009 (excluding Latvia, Lithuania, Port[...]Article : Périodique
FRANÇAIS : Les surdoses sont actuellement la principale cause de décès chez les toxicomanes par voie d'injection. Les victimes de surdoses sont principalement des hommes de 20 à 40 ans, qui, dans la plupart des cas, sont des consommateurs d'op[...]Article : Périodique
S. M. HELMER ; G. BURKHART ; J. MATIAS ; C. BUCK ; F. ENGLING CARDOSO ; J. VICENTE |Background: Substance use in European adolescents remains a serious health concern. Assessing what affects adolescents' substance use is crucial for implementing effective prevention. This study aims to examine alcohol and cannabis use-related b[...]Périodique
L. DE LA FUENTE ; SAAVEDRA P. ; G. BARRIO ; L. ROYUELA ; J. VICENTE | 1996FRANÇAIS : La pureté et la composition de l'héroïne ont été étudiées dans 17 provinces espagnoles et corrélées à la prévalence et aux changements de l'usage intraveineux. Il existe de grandes variations géographiques de la pureté. Celle-ci s'es[...]Rapport
The DRD-Standard is the Drug-Related Deaths Standard for the Member States of the European Union. It is the standard protocol for extracting and collecting data, reporting key figures to the EMCDDA and sending data to the EMCDDA. Each year, data[...]Article : Périodique
J. MOUNTENEY ; P. GRIFFITHS ; R. SEDEFOV ; A. NOOR ; J. VICENTE ; R. SIMON |Aim: A central task for the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) is to produce an annual report of the latest data available on drug demand and drug supply in Europe. This paper is intended to facilitate a better unde[...]Article : Périodique
L. MONTANARI ; A. PIRONA ; B. GUARITA ; D. HEDRICH ; J. MOUNTENEY ; J. VICENTE |ENGLISH: OBJECTIVE: The article describes an epidemiological indicator called Treatment Demand Indicator (TDI). The TDI aims to provide professionals and researchers with a common European methodology for collecting and reporting core data on d[...]Document texte divers
EMCDDA Conference on 20 years of monitoring and communicating evidence on drugs (21-22 September 2015; Lisbon) ; L. MONTANARI ; B. GUARITA ; A. PIRONA ; I. GIRAUDON ; D. HEDRICH ; R. SIMON ; J. VICENTE | Lisbon : OEDT / EMCDDA | 2015Comparable and reliable information on the numbers and characteristics of those entering specialised drug treatment in EU Member States is essential for understanding the European drug problem. The EMCDDA has been collecting data on drug treatme[...]Rapport
OEDT = EMCDDA ; L. MONTANARI ; B. GUARITA ; A. NOOR ; L. WIESSING ; F. GOMES ; D. HEDRICH ; A. PIRONA ; R. SIMON ; J. VICENTE | Lisbon : OEDT / EMCDDA | Manuals | 2012FRANÇAIS : L'indicateur de demande de traitement, ou TDI (Treatment Demand Indicator), a été établi en 2000 à partir des travaux du groupe de coopération du Conseil de l'Europe pour la lutte contre l'abus et le trafic de drogues (Groupe Pompido[...]Article : Périodique
Data on newly diagnosed HIV infections and HIV prevalence in 2005 to 2010 suggest falling infection rates in injecting drug users (IDUs) in the European Union (EU). However, recent increases in HIV and hepatitis C virus (HCV) infection rates in [...]Article : Périodique
G. BARRIO ; L. MONTANARI ; M. J. BRAVO ; B. GUARITA ; L. DE LA FUENTE ; J. PULIDO ; J. VICENTE |We estimate trends and geographical differences in the heroin epidemic in the European Union plus Croatia and Turkey by analyzing aggregated data on first heroin treatment admissions (cases) during 2000-2009. In 2005-2009 the proportion of drug [...]Chapitre
Les usages de substances en Europe sont inégalement répartis selon les territoires et concernent souvent les jeunes générations. C'est particulièrement vrai à propos du cannabis et des substances stimulantes et hallucinogènes (les opiacés étant [...]